AAAAAA

   
Results: 1-11 |
Results: 11
Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU
Authors: Gomez-Manzano, C Lemoine, MG Hu, M He, J Mitlianga, P Liu, TJ Yung, AWK Fueyo, J Groves, MD
Citation: C. Gomez-manzano et al., Adenovirally-mediated transfer of E2F-1 potentiates chemosensitivity of human glioma cells to temozolomide and BCNU, INT J ONCOL, 19(2), 2001, pp. 359-365
Co-expression of E2F-2 enhances the p53 anti-cancer effect in human gliomacells
Authors: Mitlianga, PG Kyritsis, AP Gomez-Manzano, C Lemoine, MG Hu, M Liu, TJ Yung, WKA Fueyo, J
Citation: Pg. Mitlianga et al., Co-expression of E2F-2 enhances the p53 anti-cancer effect in human gliomacells, INT J ONCOL, 18(2), 2001, pp. 343-347
Delivery of cell cycle genes to block astrocytoma growth
Authors: Fueyo, J Gomez-Manzano, C Liu, TJ Yung, WKA
Citation: J. Fueyo et al., Delivery of cell cycle genes to block astrocytoma growth, J NEURO-ONC, 51(3), 2001, pp. 277-287
Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2
Authors: Gomez-Manzano, C Mitlianga, P Fueyo, J Lee, HY Hu, M Spurgers, KB Glass, TL Koul, D Liu, TJ McDonnell, TJ Yung, WKA
Citation: C. Gomez-manzano et al., Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2, CANCER RES, 61(18), 2001, pp. 6693-6697
Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
Authors: Im, SA Kim, JS Gomez-Manzano, C Fueyo, J Liu, TJ Cho, MS Seong, CM Lee, SN Hong, YK Yung, WKA
Citation: Sa. Im et al., Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF, BR J CANC, 84(9), 2001, pp. 1252-1257
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo (vol 19, pg 2, 2000)
Authors: Fueyo, J Gomez-Manzano, C Alemany, R Lee, PSN McDonnell, TJ Mitlianga, P Shi, YX Levin, VA Yung, WKA Kyritsis, AP
Citation: J. Fueyo et al., A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo (vol 19, pg 2, 2000), ONCOGENE, 19(43), 2000, pp. 5038-5038
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Authors: Fueyo, J Gomez-Manzano, C Alemany, R Lee, PSY McDonnell, TJ Mitlianga, P Shi, YX Levin, VA Yung, WKA Kyritsis, AP
Citation: J. Fueyo et al., A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo, ONCOGENE, 19(1), 2000, pp. 2-12
Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis (Review)
Authors: Gomez-Manzano, C Fueyo, J Alameda, F Kyritsis, AP Yung, WKA
Citation: C. Gomez-manzano et al., Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis (Review), INT J MOL M, 3(1), 1999, pp. 81-85
Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses
Authors: Alemany, R Gomez-Manzano, C Balague, C Yung, WKA Curiel, DT Kyritsis, AP Fueyo, J
Citation: R. Alemany et al., Gene therapy for gliomas: Molecular targets, adenoviral vectors, and oncolytic adenoviruses, EXP CELL RE, 252(1), 1999, pp. 1-12
Antiangiogenesis treatment for gliomas: Transfer of antisense vascular endothelial growth factor inhibits tumor growth in vivo
Authors: Im, SA Gomez-Manzano, C Fueyo, J Liu, TJ Ke, LD Kim, JS Lee, HY Steck, PA Kyritsis, AP Yung, WKA
Citation: Sa. Im et al., Antiangiogenesis treatment for gliomas: Transfer of antisense vascular endothelial growth factor inhibits tumor growth in vivo, CANCER RES, 59(4), 1999, pp. 895-900
Targeting in gene therapy for gliomas
Authors: Fueyo, J Gomez-Manzano, C Yung, WKA Kyritsis, AP
Citation: J. Fueyo et al., Targeting in gene therapy for gliomas, ARCH NEUROL, 56(4), 1999, pp. 445-448
Risultati: 1-11 |